Cichero E - Search Results

1

Virtual Screening Combined with Enzymatic Assays to Guide the Discovery of Novel SIRT2 Inhibitors.

Scarano N, Abbotto E, Musumeci F, Salis A, Brullo C, Fossa P, Schenone S, Bruzzone S, Cichero E. Scarano N, et al. Among authors: cichero e. Int J Mol Sci. 2023 May 27;24(11):9363. doi: 10.3390/ijms24119363. Int J Mol Sci. 2023. PMID: 37298312 Free PMC article.

2

Rational design, synthesis and biological evaluation of new 1,5-diarylpyrazole derivatives as CB1 receptor antagonists, structurally related to rimonabant.

Menozzi G, Fossa P, Cichero E, Spallarossa A, Ranise A, Mosti L. Menozzi G, et al. Among authors: cichero e. Eur J Med Chem. 2008 Dec;43(12):2627-38. doi: 10.1016/j.ejmech.2008.01.043. Epub 2008 Feb 8. Eur J Med Chem. 2008. PMID: 18342403

3

Exploring the binding features of rimonabant analogues and acyclic CB1 antagonists: docking studies and QSAR analysis.

Cichero E, Menozzi G, Spallarossa A, Mosti L, Fossa P. Cichero E, et al. J Mol Model. 2008 Dec;14(12):1131-45. doi: 10.1007/s00894-008-0356-2. Epub 2008 Aug 12. J Mol Model. 2008. PMID: 18696129

4

Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses.

Cichero E, Cesarini S, Fossa P, Spallarossa A, Mosti L. Cichero E, et al. Eur J Med Chem. 2009 May;44(5):2059-70. doi: 10.1016/j.ejmech.2008.10.014. Epub 2008 Nov 1. Eur J Med Chem. 2009. PMID: 19046616

5

Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitor.

Cichero E, Cesarini S, Spallarossa A, Mosti L, Fossa P. Cichero E, et al. J Mol Model. 2009 Apr;15(4):357-67. doi: 10.1007/s00894-008-0402-0. Epub 2008 Dec 9. J Mol Model. 2009. PMID: 19066996

6

Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses.

Cichero E, Cesarini S, Spallarossa A, Mosti L, Fossa P. Cichero E, et al. J Mol Model. 2009 Jul;15(7):871-84. doi: 10.1007/s00894-008-0441-6. Epub 2009 Jan 20. J Mol Model. 2009. PMID: 19153780

7

CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists.

Cichero E, Cesarini S, Mosti L, Fossa P. Cichero E, et al. J Mol Model. 2010 Apr;16(4):677-91. doi: 10.1007/s00894-009-0580-4. Epub 2009 Oct 1. J Mol Model. 2010. PMID: 19809837

8

CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists.

Cichero E, Cesarini S, Mosti L, Fossa P. Cichero E, et al. J Mol Model. 2010 Sep;16(9):1481-98. doi: 10.1007/s00894-010-0664-1. Epub 2010 Feb 20. J Mol Model. 2010. PMID: 20174844

9

1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.

Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L. Franchini S, et al. Among authors: cichero e. Eur J Med Chem. 2010 Sep;45(9):3740-51. doi: 10.1016/j.ejmech.2010.05.023. Epub 2010 May 15. Eur J Med Chem. 2010. PMID: 20605276

10

3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses.

Cichero E, Buffa L, Fossa P. Cichero E, et al. J Mol Model. 2011 Jul;17(7):1537-50. doi: 10.1007/s00894-010-0857-7. Epub 2010 Oct 5. J Mol Model. 2011. PMID: 20922443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters